U.S. Luxury Stock News

NYSE:LHX
NYSE:LHXAerospace & Defense

What Does L3Harris Technologies (LHX) Leadership Shakeup Mean For Its Defense Push?

L3Harris Technologies (NYSE:LHX) appointed Sam Mehta as CEO and President, alongside extensive leadership and board changes. The company reshuffled its board leadership and introduced new executive roles, indicating a refreshed governance structure. L3Harris highlighted advanced multi domain defense and interoperable communications capabilities at recent key U.S. Army events. The leadership moves and technology showcases reflect a meaningful shift in how L3Harris positions itself within the...
NYSE:UCB
NYSE:UCBBanks

United Community Banks (UCB) Could Be 8% Undervalued On Its Dividend Rise And Leadership Changes

United Community Banks (UCB) recently drew investor attention after its board approved a 4% rise in the quarterly cash dividend to $0.26 per share, along with several senior leadership changes across finance and commercial banking. See our latest analysis for United Community Banks. At a share price of $35.11, United Community Banks has given investors an 11.64% year to date share price return. The 1 year total shareholder return of 9.35% and 3 year total shareholder return of 42.01% point to...
NasdaqGS:ATLC
NasdaqGS:ATLCConsumer Finance

Atlanticus Holdings (ATLC) Could Be 30% Below Fair Value Following Preferred Dividend Declaration

Atlanticus Holdings (ATLC) recently announced a quarterly cash dividend of $0.476563 per share on its Series B Cumulative Perpetual Preferred Stock, a move that draws attention to the capital structure behind the common stock. See our latest analysis for Atlanticus Holdings. At a share price of $93.95, Atlanticus Holdings has given investors a year to date share price return of 41.60%, while the 1 year total shareholder return of 41.19% and 3 year total shareholder return of 166.15% point to...
NYSE:UAMY
NYSE:UAMYMetals and Mining

United States Antimony (UAMY) Stock Looks Expensive Despite A 47% Fair Value Gap

United States Antimony has delivered an extremely strong 3 year share price return, yet its current valuation signals are pulling in different directions, with a Discounted Cash Flow (DCF) estimate pointing to a large gap to intrinsic value while market multiples suggest the stock screens as expensive. Over the past 3 years, United States Antimony has returned very large multiples for shareholders, which puts extra focus on whether the current price can be justified by future cash flows. The...
NasdaqGS:CPB
NasdaqGS:CPBFood

Is Campbell's (CPB) Still Cheap Or Merely Reasonable?

Campbell's stock has had a difficult run over the past few years, yet the current checks on its valuation still lean toward the shares looking cheap rather than expensive. Campbell's shareholders have seen the stock decline 36.5% over the past 3 years, which raises the question of whether sentiment has swung too far compared with the underlying business. Future valuation can be influenced by how consistently Campbell's converts revenue into cash flow. Any sustained pressure on margins would...
NYSE:NVO
NYSE:NVOPharmaceuticals

Novo Nordisk (NVO) Stock May Trade Below Fair Value Despite Obesity Market Lawsuit

Novo Nordisk stock combines a weak three year share price record with valuation checks that still lean supportive, which raises questions about how much pessimism is already reflected in today’s price. Over the past three years the share price has declined 45.7%, which suggests investors have meaningfully reset their expectations for the business. Expectations around Novo Nordisk’s ability to grow and defend its position in the obesity treatment market can support the investment case. At the...
NasdaqGS:PEP
NasdaqGS:PEPBeverage

PepsiCo’s New HR Chief and Gatik Tie-Up Might Change The Case For Investing In PepsiCo (PEP)

PepsiCo recently appointed Nidhima M., a veteran HR leader with nearly 19 years of global experience, as Senior Director of HR for India, Bangladesh and Nepal, while also preparing to release its third-quarter 2026 results and deepening its commercial partnership with autonomous trucking firm Gatik. These developments highlight PepsiCo’s growing emphasis on international leadership, technology-enabled logistics, and overseas operations as central pillars of its longer-term diversification...
NasdaqGM:SEPN
NasdaqGM:SEPNPharmaceuticals

Is Septerna (SEPN) Elevating Its Clinical Strategy With a Veteran Regulatory Leader at the Helm?

Septerna, Inc. recently appointed Rajiv Patni, M.D., as Chief Medical Officer, adding a physician-scientist with more than 25 years of global biopharmaceutical leadership experience across research, development, regulatory, and medical affairs roles. His track record contributing to 10 regulatory approvals or label expansions and leadership roles at companies that were later acquired may influence how investors view Septerna’s ability to advance its pipeline and execute on clinical...
NYSE:MUR
NYSE:MUROil and Gas

Oil Stocks To Watch If Strait Of Hormuz Risks Start To Ease

Talks over new shipping routes and mine clearance in the Strait of Hormuz are reshaping how investors think about oil flows and risk. When a chokepoint for global crude looks a little less fragile yet still uncertain, pricing, margins and capital plans for integrated energy giants can all come under review. This article walks through three large oil and gas stocks exposed to this news and how the shifting risk picture could matter for your portfolio. The three integrated giants covered below...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna (MRNA) Is Up 151.8% After First Positive Phase 3 mRNA Cancer Therapy Result - What's Changed

In August 2026, Merck & Co. and Moderna reported positive Phase 3 results from the INTerpath-001 trial, showing that individualized mRNA neoantigen therapy intismeran (V940/mRNA-4157) plus KEYTRUDA improved recurrence-free and distant metastasis-free survival versus KEYTRUDA alone in resected stage IIB–IV melanoma, with no new safety signals. This is the first positive Phase 3 outcome for both an individualized neoantigen therapy and an mRNA-based cancer therapy, highlighting a potential...
NYSE:WCN
NYSE:WCNCommercial Services

Waste Connections (WCN) Stock Looks Fully Priced Despite Cash Flow Upside

Waste Connections stock has delivered a 33.4% total return over the last five years, yet the current valuation signals are split. The intrinsic value estimate from a Discounted Cash Flow (DCF) model points to upside relative to the market price, while earnings based multiples suggest the shares trade at a premium. The 33.4% five year return suggests Waste Connections has already created solid value for long term shareholders, so fresh buyers now need to think carefully about what is priced...
NYSE:AGX
NYSE:AGXConstruction

Argan (AGX) Stock May Be Pricey With Earnings Needing To Catch Up

Argan stock has delivered an exceptionally strong move over the past three years, yet on the current checks it screens as expensive rather than a clear bargain. After that run, investors are now facing a share price that has pulled back recently but still carries a low overall value score and an overvalued read on market multiples. Argan has returned very roughly 10x over the past three years, which means even small changes in expectations can have a meaningful impact on what feels like a...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

JD.com (JD) Just Gave Investors Something To Think About

JD.com (NasdaqGS:JD) has drawn fresh investor attention after committing RMB 10 billion to a global robotics push by 2028, targeting homes, businesses, and public services with extensive after-sales networks and new engineering jobs. See our latest analysis for JD.com. Investors have reacted only modestly so far, with JD.com’s 7 day share price return of 1.87% and year to date share price return roughly flat. The 1 year total shareholder return is down 4.48%, suggesting momentum is still...
NYSE:NKE
NYSE:NKELuxury

Is Nike’s (NKE) Crenshaw Rec Bet a Blueprint for Deeper Community‑Driven Brand Moats?

Earlier this month, Foot Locker announced The Crenshaw Rec by Foot Locker in Los Angeles, a community-focused retail hub co-developed with Nike, Jordan Brand and Converse, featuring exclusive local collections, programming, and neighborhood hiring initiatives. This community-led concept illustrates how Nike is tying its brands more closely to cultural influence and local engagement, particularly with younger consumers. Now we’ll examine how this community-centric retail partnership,...
NYSEAM:TMP
NYSEAM:TMPBanks

Dividend Hike and Higher Yield Might Change The Case For Investing In Tompkins Financial (TMP)

Tompkins Financial recently announced a quarterly dividend of US$0.70 per share, lifting its annualized payout to US$2.80, an increase of 11.6% from the prior year and ahead of the Banks – Northeast industry yield, alongside expectations for higher earnings in its current fiscal year. This combination of sustained dividend growth and an anticipated improvement in earnings has reinforced Tompkins Financial’s income and quality-focused appeal for investors. We’ll now examine how Tompkins...
NYSE:AX
NYSE:AXBanks

Axos Financial (AX) Could Be 17% Undervalued On Its Niche Lending Narrative

Axos Financial (AX) has drawn fresh attention after recent trading data showed the stock at $98.82 as of 25 August 2026, with performance figures available for the past week, month and past 3 months. See our latest analysis for Axos Financial. Over the past year Axos Financial has paired a strong 13.46% 90 day share price return with a 131.16% three year total shareholder return. This suggests recent momentum has added to an already sizeable long term payoff for investors tracking both price...
NasdaqGS:MPWR
NasdaqGS:MPWRSemiconductor

Is Monolithic Power Systems (MPWR) Undervalued Following Enterprise Data Growth?

Monolithic Power Systems (MPWR) is back in focus after reporting strong growth in its Enterprise Data segment, which highlights rising demand for its power management solutions across data centers, AI workloads, and server infrastructure. See our latest analysis for Monolithic Power Systems. At a share price of $1,304.15, Monolithic Power Systems has seen its short term share price return weaken, with the 90 day share price return down 19.51%, even though the year to date share price return...
NYSE:KMT
NYSE:KMTMachinery

Kennametal (KMT) Adds Board Veterans As Its Undervalued Narrative Stays In Focus

Kennametal (KMT) has added Dawne S. Hickton and Richard J. Harshman to its Board of Directors, a governance event that gives investors fresh context for assessing the stock after recent share price moves. See our latest analysis for Kennametal. The new board appointments arrive after a mixed stretch for Kennametal, with the share price falling 16.9% over the past month and 15.8% over the past quarter, even as the 1 year total shareholder return is 39.9%, which suggests longer term momentum...
NasdaqGS:GLUE
NasdaqGS:GLUEBiotechs

Monte Rosa Therapeutics (GLUE) Looks Pricey As Phase 2 Progress Keeps The Story Alive

Monte Rosa Therapeutics (GLUE) dosed the first patient in its MODeFIRe-1 Phase 2 trial of MRT-2359 with apalutamide for AR mutation-positive metastatic castration-resistant prostate cancer, building on earlier combination data with enzalutamide. See our latest analysis for Monte Rosa Therapeutics. The MRT-2359 update comes after a sharp 36.08% decline in the 30-day share price return and a 24.05% decline over 90 days, even as the 1-year total shareholder return of 211.78% and 3-year total...
NYSE:JPM
NYSE:JPMBanks

Why Is JPMorgan Chase (JPM) Balancing Affordable Housing Plans And Lawsuit Risk?

JPMorgan Chase (NYSE:JPM) and several large US banks have committed billions of dollars to new affordable housing efforts through JPMorgan’s American Dream Initiative. The housing push targets the ongoing national shortage of affordable homes and responds to changing conditions in the US mortgage market. JPMorgan and Morgan Stanley are also facing fresh shareholder lawsuits that question their advisory roles in certain private equity buyouts. The new commitments and legal actions raise fresh...
NasdaqGS:MCBS
NasdaqGS:MCBSBanks

MetroCity Bankshares (MCBS) Stock Could Be Undervalued As Excess Returns Hold Up

After almost doubling over the past five years, MetroCity Bankshares now faces a more nuanced valuation picture, with the Excess Returns intrinsic value estimate suggesting the stock trades at a sizeable discount even as market multiples look broadly in line. MetroCity Bankshares has returned 99.1% over five years, which puts current pricing under the spotlight for anyone considering a fresh entry or adding to an existing position. The key support for the valuation can come from the bank's...
NasdaqGM:PSNL
NasdaqGM:PSNLLife Sciences

Why Personalis (PSNL) Is Up 24.0% After New VA MVP Genomics Task Order Win

Personalis, Inc. has received a new task order under its contract with the U.S. Department of Veterans Affairs’ Million Veteran Program, effective 30 September 2026 and valued at up to US$18.3 million, bringing the cumulative value of its VA MVP task orders to approximately US$243.3 million. This additional VA MVP work highlights Personalis’ growing role as a key genomics partner to a major federal healthcare program focused on large-scale precision medicine research. We’ll now examine how...
NYSE:MOD
NYSE:MODBuilding

MasTec Stock And Two Industrials Backed By US Grid And Data Center Demand

With Canada and the US trading tariff blows on about $40b of goods, cross border supply chains face real friction and some companies may find new demand at home. This kind of disruption often rewards investors who identify which businesses are exposed to the news for the right reasons. The article examines three stocks from our North American onshoring screener that may be positioned to benefit from this shift. The three stocks below are just a starting sample, since the full screen surfaced...
NYSE:CHWY
NYSE:CHWYSpecialty Retail

Is Chewy (CHWY) Undervalued Ahead Of Its September 9 Earnings?

Chewy (CHWY) is back in focus after a 2% gain in its latest session, which came despite a mixed broader market as investors look ahead to the company’s earnings report on September 9, 2026. See our latest analysis for Chewy. Chewy’s recent 7.16% 7 day share price return and 18.36% 30 day share price return suggest short term momentum is improving, although the 39.41% decline in 1 year total shareholder return shows longer term performance is still weak. If you are looking beyond Chewy to see...